Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Balance beginning (in shares) at Dec. 31, 2022		143,034,225
Balance beginning at Dec. 31, 2022	$ 376,905	$ 14	$ 371,072	$ 21,772	$ (15,953)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		163,096
Common stock issued upon exercise of stock options	23		23
Vested common stock awards (in shares)		70,670
Stock-based compensation	2,915		2,915
Net income (loss)	9,769			9,769
Other comprehensive income (loss)	1,530				1,530
Ending balance (in shares) at Mar. 31, 2023		143,267,991
Ending balance at Mar. 31, 2023	391,142	$ 14	374,010	31,541	(14,423)
Balance beginning (in shares) at Dec. 31, 2022		143,034,225
Balance beginning at Dec. 31, 2022	376,905	$ 14	371,072	21,772	(15,953)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	34,236
Other comprehensive income (loss)	3,723
Ending balance (in shares) at Sep. 30, 2023		144,198,529
Ending balance at Sep. 30, 2023	424,087	$ 14	380,295	56,008	(12,230)
Balance beginning (in shares) at Mar. 31, 2023		143,267,991
Balance beginning at Mar. 31, 2023	391,142	$ 14	374,010	31,541	(14,423)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		208,807
Common stock issued upon exercise of stock options	31		31
Vested common stock awards (in shares)		21,926
Stock-based compensation	3,018		3,018
Net income (loss)	(6,464)			(6,464)
Other comprehensive income (loss)	4,776				4,776
Ending balance (in shares) at Jun. 30, 2023		143,498,724
Ending balance at Jun. 30, 2023	392,503	$ 14	377,059	25,077	(9,647)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		582,240
Common stock issued upon exercise of stock options	90		90
Vested common stock awards (in shares)		117,565
Stock-based compensation	3,146		3,146
Net income (loss)	30,931			30,931
Other comprehensive income (loss)	(2,583)				(2,583)
Ending balance (in shares) at Sep. 30, 2023		144,198,529
Ending balance at Sep. 30, 2023	424,087	$ 14	380,295	56,008	(12,230)
Balance beginning (in shares) at Dec. 31, 2023		145,706,531
Balance beginning at Dec. 31, 2023	422,507	$ 15	382,854	45,570	(5,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		585,760
Common stock issued upon exercise of stock options	83		83
Vested common stock awards (in shares)		212,633
Stock-based compensation	2,781		2,781
Net income (loss)	(13,913)			(13,913)
Other comprehensive income (loss)	(3,274)				(3,274)
Ending balance (in shares) at Mar. 31, 2024		146,504,924
Ending balance at Mar. 31, 2024	408,184	$ 15	385,718	31,657	(9,206)
Balance beginning (in shares) at Dec. 31, 2023		145,706,531
Balance beginning at Dec. 31, 2023	422,507	$ 15	382,854	45,570	(5,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(70,175)
Other comprehensive income (loss)	(1,497)
Ending balance (in shares) at Sep. 30, 2024		145,886,615
Ending balance at Sep. 30, 2024	358,856	$ 15	390,875	(24,605)	(7,429)
Balance beginning (in shares) at Mar. 31, 2024		146,504,924
Balance beginning at Mar. 31, 2024	408,184	$ 15	385,718	31,657	(9,206)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		499,365
Common stock issued upon exercise of stock options	158		158
Vested common stock awards (in shares)		206,049
Stock-based compensation	2,536		2,536
Net income (loss)	(19,499)			(19,499)
Other comprehensive income (loss)	(741)				(741)
Ending balance (in shares) at Jun. 30, 2024		147,210,338
Ending balance at Jun. 30, 2024	390,638	$ 15	388,412	12,158	(9,947)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of stock options (in shares)		8,509
Common stock issued upon exercise of stock options	$ 4		4
Vested common stock awards (in shares)		167,768
Sponsor vesting shares forfeited (in shares)	(1,500,000)
Stock-based compensation	$ 2,459		2,459
Net income (loss)	(36,763)			(36,763)
Other comprehensive income (loss)	2,518				2,518
Ending balance (in shares) at Sep. 30, 2024		145,886,615
Ending balance at Sep. 30, 2024	$ 358,856	$ 15	$ 390,875	$ (24,605)	$ (7,429)